Sciecure has been devoting on the development, manufacturing, and sale for the new and generic drugs with the high quality for both the domestic and international markets.Some have been passed the inspections by CFDA.With the growing demanding, our company hasfocused to develop the overseas markets in the pharmaceutical field, a number of these products has been submittedin Europe and USA.
Marketing Authorization (MA) of Celecoxib capsules100mg & 200mgare granted by Portugal National Authority of Medicines and Health Productson 09 November, 2017.
These are the great achievements for our company, and we will continue to develop more high quality drugs to benefit the societies.
Prev：Marketing Authorization(ANDA) of Budesonide Capsule 3mg is granted by US FDA
Next：CFDA's Vice Minister Mr. Sun Xianze andPresident of National Institute for Food and Drug Control Visiting Beijing Sciecure Pharmaceutical Co. Ltd.